CLSD - Clearside Biomedical, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 64.13M
Enterprise Value 23.94M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)48.54
Price/Book (mrq)6.22
Enterprise Value/Revenue 24.33
Enterprise Value/EBITDA -0.83

Trading Information

Stock Price History

Beta (5Y Monthly) 2.08
52-Week Change 3-11.54%
S&P500 52-Week Change 33.90%
52 Week High 31.8550
52 Week Low 30.9000
50-Day Moving Average 31.0760
200-Day Moving Average 31.2229

Share Statistics

Avg Vol (3 month) 3178.18k
Avg Vol (10 day) 390.93k
Shares Outstanding 561.67M
Implied Shares Outstanding 6N/A
Float 853.69M
% Held by Insiders 17.45%
% Held by Institutions 128.13%
Shares Short (May 14, 2023) 4568.37k
Short Ratio (May 14, 2023) 44.79
Short % of Float (May 14, 2023) 40.99%
Short % of Shares Outstanding (May 14, 2023) 40.92%
Shares Short (prior month Apr 13, 2023) 4269.61k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 0.00%
Operating Margin (ttm)-3,072.76%

Management Effectiveness

Return on Assets (ttm)-46.80%
Return on Equity (ttm)-201.05%

Income Statement

Revenue (ttm)984k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-98.80%
Gross Profit (ttm)1.12M
EBITDA -30.12M
Net Income Avi to Common (ttm)-34.58M
Diluted EPS (ttm)-0.6000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)41.42M
Total Cash Per Share (mrq)0.67
Total Debt (mrq)1.22M
Total Debt/Equity (mrq)45.30
Current Ratio (mrq)8.54
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-24.45M
Levered Free Cash Flow (ttm)-17.35M